Controlled Clinical TrialtaVNSn = 36

Short-term transcutaneous non-invasive vagus nerve stimulation may reduce disease activity and pro-inflammatory cytokines in rheumatoid arthritis: results of a pilot study

Drewes A, Brock C, Rasmussen S, Møller H, Brock B, Deleuran B, Farmer A, Pfeiffer-Jensen M

Scandinavian Journal of Rheumatology · 2021

Key finding

Four days of non-invasive vagus nerve stimulation reduced DAS28-CRP, CRP and interferon-gamma in RA patients with high disease activity in this open-label proof-of-concept study.

Condition
Rheumatoid Arthritis
Stimulation
taVNS
Evidence tier
Controlled Clinical Trial
Participants
36
View on DOI

Cite this study

Drewes, A., Brock, C., Rasmussen, S., Møller, H., Brock, B., Deleuran, B., Farmer, A., & Pfeiffer-Jensen, M. (2021). Short-term transcutaneous non-invasive vagus nerve stimulation may reduce disease activity and pro-inflammatory cytokines in rheumatoid arthritis: results of a pilot study. Scandinavian Journal of Rheumatology, 50(1), 20-27. https://doi.org/10.1080/03009742.2020.1764617

Related studies in Rheumatoid Arthritis

Summary by Vagus Research. Always consult the primary source for the authoritative record.

Stay Current with the Research

Join researchers and practitioners exploring the science of vagus nerve stimulation. Receive curated research summaries and evidence updates.

No spam. Unsubscribe at any time. We respect your privacy.